Alfuzosine Sandoz 10 mg tabl. prol.-rel.

Valsts: Beļģija

Valoda: angļu

Klimata pārmaiņas: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Aktīvā sastāvdaļa:

Alfuzosin Hydrochloride 10 mg

Pieejams no:

Sandoz SA-NV

ATĶ kods:

G04CA01

SNN (starptautisko nepatentēto nosaukumu):

Alfuzosin Hydrochloride

Deva:

10 mg

Zāļu forma:

Prolonged-release tablet

Kompozīcija:

Alfuzosin Hydrochloride 10 mg

Ievadīšanas:

Oral use

Ārstniecības joma:

Alfuzosin

Produktu pārskats:

CTI code: 294192-08 - Pack size: 100 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 294192-09 - Pack size: 180 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 294192-04 - Pack size: 50 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 294192-05 - Pack size: 60 - Commercialisation status: YES - FMD code: 07613421000097 - CNK code: 2414944 - Delivery mode: Medical prescription; CTI code: 294192-06 - Pack size: 60 (60 x 1) - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 294192-07 - Pack size: 90 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 294192-01 - Pack size: 10 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 294192-02 - Pack size: 20 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 294192-03 - Pack size: 30 - Commercialisation status: YES - FMD code: 07613421000080 - CNK code: 2414969 - Delivery mode: Medical prescription

Autorizācija statuss:

Commercialised: Yes

Autorizācija datums:

2007-04-16